Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KALV will rise by +9.72% over the next 2 Weeks and hit $29.36 by Thursday, May 28, 2026. In that time frame, KALV's share price is expected to range between $27.08 and $31.50.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 28, 2026 | 27.08 | 29.36 | 31.50 |
| May 27, 2026 | 27.30 | 29.54 | 31.77 |
| May 26, 2026 | 26.11 | 28.50 | 30.80 |
| May 25, 2026 | 26.10 | 28.38 | 30.65 |
| May 22, 2026 | 26.28 | 28.61 | 30.89 |
| May 21, 2026 | 25.79 | 28.02 | 30.40 |
| May 20, 2026 | 25.82 | 28.20 | 30.57 |
| May 19, 2026 | 24.79 | 27.16 | 29.52 |
| May 18, 2026 | 24.80 | 27.04 | 29.26 |
| May 15, 2026 | 25.17 | 27.27 | 29.55 |
KALV shares fell -0.15% in Thursday, May 14, 2026's trading session, dropping from a previous close of $26.80 to move at $26.76. The stock demonstrated notable intraday movement (see KALV's key stats for a full breakdown), fluctuating between $26.75 and $26.82, a +0.25% trading range. While recent weeks have seen some volatility, KALV has managed to secure a +0.38% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 3.47M shares changing hands, 1.19M more than the previous session. This amounted to $92.92M in total market activity.
Will KALV Continue Its Upward Trend?
According to analyst ratings and projections for KALV, KalVista Pharmaceuticals, Inc. shares are anticipated to increase by +15.05%, potentially reaching $31.50 per share by May 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for KALV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the KALV stock forecast, now is a good time to buy KALV stock because its current trading price is -8.86% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on KALV covering social and institutional perspectives.
KALV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KALV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 71.96% to 79.54%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 64.97%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 60.69%, points to growing bullish momentum over the long term. Insights into KALV's shareholder base show how institutional investors are positioning themselves during these momentum shifts
KalVista Pharmaceuticals Short-Term Forecasts
KALV Forecast For Next 5 Days
Our algorithm anticipates KalVista Pharmaceuticals (KALV) stock could hit $24.76 by May 22, 2026. This represents a -7.47% fall from today's price, following a -6.59% change over the past five days.
KALV Forecast For Next 30 Days
Based on analysis of market trends, the outlook for KalVista Pharmaceuticals, Inc. (KALV) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $28.38, which would mean a +6.05% increase from the current price of $26.76. Projections for this period range from a high of $33.87 to a low of $23.03.
KALV Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for KalVista Pharmaceuticals's price over the next three months point to a rise. KALV stock is expected to peak at $28.66 on Jul 22, 2026 after potentially dipping to $25.30 on May 18, 2026. On average, KALV is likely to trade around $26.98 in the coming 90 days.
KalVista Pharmaceuticals Stock Forecast 2025
Based on our predictive models, KalVista Pharmaceuticals (KALV) is expected to trade between $24.84 and $29.77 throughout 2026. This would result in an average price of $27.43, potentially offering investors a +2.50% return from current levels.
KalVista Pharmaceuticals, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, KalVista Pharmaceuticals, Inc. (KALV) is positioned to show a strong performance in May 2026. The price is predicted to move between $25.30 and $27.54, settling at an average of $26.48. This could translate to a -1.05% loss.
June 2026
Based on current market signals, KalVista Pharmaceuticals, Inc. is projected to trend june 2026. We forecast a trading range from $25.80 to $28.09, with a likely average price of $26.95. Investors could expect a potential return of +0.71%.
July 2026
Our predictive algorithms indicate KalVista Pharmaceuticals, Inc. stock may see a shift in July 2026. The expected range spans $25.83–$28.66, with an average target of $27.17. This represents a positive outlook and a possible gain of +1.53%.
August 2026
Analyzing established trends, KalVista Pharmaceuticals, Inc. looks set to move in August 2026. Projections place the stock between $26.14 and $28.44, averaging around $27.26. This suggests a +1.87% gain from current levels.
September 2026
Market indicators suggest KalVista Pharmaceuticals, Inc. could experience notable changes during September 2026. Prices could fluctuate within $26.24 to $29.35, with a midpoint forecast of $27.41. The stock might deliver a +2.43% gain.
October 2026
Forecasting for October 2026, models estimate that KalVista Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $25.23 and $29.77, averaging $27.76. This signals a positive trajectory with potential returns around +3.74%.
November 2026
According to our latest forecast models, KalVista Pharmaceuticals, Inc. (KALV) is positioned to show a strong performance in November 2026. The price is predicted to move between $24.84 and $29.11, settling at an average of $27.84. This could translate to a +4.04% gain.
December 2026
Based on current market signals, KalVista Pharmaceuticals, Inc. is projected to trend december 2026. We forecast a trading range from $26.82 to $29.38, with a likely average price of $28.10. Investors could expect a potential return of +5.01%.
January 2027
Our predictive algorithms indicate KalVista Pharmaceuticals, Inc. stock may see a shift in January 2027. The expected range spans $27.06–$29.45, with an average target of $28.23. This represents a positive outlook and a possible gain of +5.49%.
February 2027
Analyzing established trends, KalVista Pharmaceuticals, Inc. looks set to move in February 2027. Projections place the stock between $27.07 and $30.17, averaging around $28.32. This suggests a +5.83% gain from current levels.
March 2027
Market indicators suggest KalVista Pharmaceuticals, Inc. could experience notable changes during March 2027. Prices could fluctuate within $27.37 to $30.90, with a midpoint forecast of $28.77. The stock might deliver a +7.51% gain.
April 2027
Forecasting for April 2027, models estimate that KalVista Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $27.87 and $29.94, averaging $28.88. This signals a positive trajectory with potential returns around +7.92%.
May 2027
According to our latest forecast models, KalVista Pharmaceuticals, Inc. (KALV) is positioned to show a strong performance in May 2027. The price is predicted to move between $27.72 and $30.14, settling at an average of $28.88. This could translate to a +7.92% gain.
KALV's history of dividends and stock splits also plays a role in long-term investor confidence.

